Adverum Biotechnologies, Inc.

12 Marks

Corp.

First Filed:Jul 25, 2016Latest Filed:Sep 17, 2024Address:100 Cardinal Way, Redwood City, CA 94063

Portfolio Overview

Registered

8(67%)

Pending

4(33%)

Top Classes

Class 42

Software, IT Services & Scientific Research

7(58%)

Class 5

Pharmaceuticals

6(50%)

TTAB Proceedings

No litigation activity

Top Firms

Owen, Wickersham & Erickson,...(Nov 2022)

Pierson Ferdinand LLP(Sep 2024)

Trademark Portfolio

12 results

(current & previous marks)

Refine by Mark/Description🔽

Filed

Registered

Last Activity

Filters

Ownership

Current12

Previous0

Status

Registered8

Pending4

Cancelled0

Abandoned0

Expired0

Mark Type

Word9

Stylized0

Design1

Combined2

NonVisual0

Class 56

Class 427

ONE AND DONE

Service Mark

Word

REGISTERED

Owner:

Serial:98977321

Filed:Sep 17, 2024

Classes:42

Registration:8104118

Registered:Jan 13, 2026

Goods & Services

Class 042: Gene therapy research; Research, development, and testing of pharmaceutical preparations for gene therapy; Research, development, and testing of pharmaceutical preparations for gene therapy for use in the treatment of ocular diseases

ONE AND DONE

Trademark

Word

PENDING

Owner:

Serial:98755607

Filed:Sep 17, 2024

Classes:5, 42

Goods & Services

Gene therapy products, namely, single-administration genetically engineered pharmaceutical preparations used in the treatment of ocular diseases; Gene therapy research; Research, development, and testing of pharmaceutical preparations for gene therapy; Research, development, and testing of pharmaceutical preparations for gene therapy for use in the treatment of ocular diseases;

97855280

Trademark

Design

PENDING

Owner:

Serial:97855280

Filed:Mar 24, 2023

Classes:5

Goods & Services

Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF) -mediated ocular diseases

LUNA

Trademark

Combined

PENDING

Owner:

Serial:97855277

Filed:Mar 24, 2023

Classes:5

Goods & Services

Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF) -mediated ocular diseases

REDEFINING SIGHT FOR LIFE.

Service Mark

Word

REGISTERED

Owner:

Serial:97698505

Filed:Nov 30, 2022

Classes:42

Registration:7249097

Registered:Dec 19, 2023

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

SEE LIFE. IN ACTION.

Service Mark

Word

REGISTERED

Owner:

Serial:97698565

Filed:Nov 30, 2022

Classes:42

Registration:7254914

Registered:Dec 26, 2023

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

SEE LIFE. IN EXPRESSION.

Service Mark

Word

REGISTERED

Owner:

Serial:97698596

Filed:Nov 30, 2022

Classes:42

Registration:7254915

Registered:Dec 26, 2023

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

SEE LIFE. IN VISION.

Service Mark

Word

REGISTERED

Owner:

Serial:97698529

Filed:Nov 30, 2022

Classes:42

Registration:7254913

Registered:Dec 26, 2023

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

PRESERVING SIGHT FOR LIFE.

Service Mark

Word

REGISTERED

Owner:

Serial:97671619

Filed:Nov 10, 2022

Classes:42

Registration:7430258

Registered:Jun 25, 2024

Goods & Services

Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

LUNA

Trademark

Word

PENDING

Owner:

Serial:97227100

Filed:Jan 19, 2022

Classes:5

Goods & Services

Ocular pharmaceuticals; Pharmaceutical preparations for the treatment of vascular endothelial growth factor (VEGF)-mediated ocular diseases

Trademark

Combined

REGISTERED

Owner:

Serial:79201245

Filed:Nov 16, 2016

Classes:5

Registration:5488639

Registered:Jun 12, 2018

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR USE IN GENE THERAPY FOR THE TREATMENT OF OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR GENE THERAPY FOR THE TREATMENT OF GENETIC DISEASES OR DISORDERS; PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF GENE THERAPY TREATABLE DISEASES, NAMELY, OSTEOARTHRITIS, NEUROLOGIC CONDITIONS, INFLAMMATORY CONDITIONS, IMMUNE-MEDIATED CONDITIONS, ENDOCRINE DISEASES, CHRONIC DEGENERATIVE DISEASES, GASTROINTESTINAL DISEASES; PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISORDERS OF THE NERVOUS SYSTEM, THE IMMUNE SYSTEM, THE CARDIO-VASCULAR SYSTEM, THE METABOLIC SYSTEM, THE RESPIRATORY SYSTEM, THE MUSCULO-SKELETAL SYSTEM, THE OCULAR AND AUDITORY SYSTEMS, AND THE GENITOURINARY SYSTEM

ADVERUM

Trademark

Word

REGISTERED

Owner:

Serial:79194977

Filed:Jul 25, 2016

Classes:5

Registration:5303797

Registered:Oct 10, 2017

Goods & Services

Gene therapy pharmaceutical preparations; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases

Adverum Biotechnologies, Inc.

Portfolio Overview

Top Classes

TTAB Proceedings

Top Firms

Trademark Portfolio

12 results

Filters

Cookie Preferences